Volume 18 • Issue 17 |
October 3, 2018 |
|
|
|
|
|
|
|
IMPORTANT INFORMATION -
DISCONTINUATION OF SECTRAL® 100 MG (ACEBUTOLOL HYDROCHLORIDE)
sanofi-aventis Canada Inc. would like to inform you that Sectral® (acebutolol hydrochloride) 100mg has been discontinued due to discontinuation of the production of the active ingredient.
Read more
|
|
|
|
|
|
IMPORTANT INFORMATION -
TEMPORARY SHORTAGE OF PRIMAQUINE® (PRIMAQUINE PHOSPHATE)
sanofi-aventis Canada Inc. would like to inform you that Primaquine® (primaquine phosphate) is on temporary shortage due to API availability.
Read more
|
|
|
|
|
|
IMPORTANT INFORMATION -
TEMPORARY SHORTAGE OF CYCLOMEN® 50MG AND CYCLOMEN® 100MG (DANAZOL)
sanofi-aventis Canada Inc. would like to inform you that Cyclomen® 50mg and Cyclomen® 100mg (danazol) are on temporary shortages due to a delay in API availability.
Read more
|
|
|
|
|
|
CHECK OUT OUR NEWEST COLD-FX® FIRST SIGNS® PRODUCT
Introducing COLD-FX® First Signs® Nighttime; a Nighttime Sleep Aid containing Melatonin plus Naturally Sourced Ginger, Andrographis and CVT-E002®.
Read more
|
|
|
|
|
|
|
TEAR-GEL® – FOR DRY EYE RELIEF
Tear-Gel® is a highly viscous clear gel to treat mild to severe dry eyes. It forms a protective film with a long corneal contact time and provides long-lasting relief without blurring.
Read more
|
|
|
|
|
|
PREVENTION AND TREATMENT OF IRON DEFICIENCY
Read more
|
|
|
|
|
|
COLD-FX® DAILY SUPPORT - A NATURAL HEALTH PRODUCT, PROVEN BY SCIENCE
COLD-FX® Daily Support is an evidence-based product that has been assessed with more than 10 years of research, including 6 published randomized, double-blinded and placebo controlled clinical trials and 20+ published articles studying the effects of CVT-E002® in over 1600 subjects.
Read more
|
|
|